DIABETES OBESITY & METABOLISM-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=555444, encodeId=cb2155544477, content=一般投稿多久会收到拒绝信？十天了一直是under review状态，感觉会悲剧的文章，只是想投投看看reviewer意见，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=866, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c65a82050, createdName=lalanihaoya, createdTime=Thu Apr 26 23:04:00 CST 2018, time=2018-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555433, encodeId=dfb8555433bc, content=我想咨询下投稿后就会立即显示under review吗?谢谢!aug_fs_44765140 2018-04-10 12:40:00 发表: 回复很及时.两周果断被拒,不过editor态度很nice的.reviewers也给了不少建设性意见, beContent=aug_fs_44765140 2018-04-10 12:40:00 发表: 回复很及时.两周果断被拒,不过editor态度很nice的.reviewers也给了不少建设性意见, objectType=tool_impact_factor, channel=null, level=null, likeNumber=313, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=29d42068457, createdName=1361ef91b0m, createdTime=Thu Apr 26 00:00:00 CST 2018, time=2018-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554766, encodeId=b1d4554e66ee, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：回复很及时，两周果断被拒；不过editor态度很nice的，reviewers也给了不少建设性意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=379, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=40232188750, createdName=aug_fs_44765140, createdTime=Tue Apr 10 12:40:00 CST 2018, time=2018-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833794, encodeId=4fff833e943d, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：这个杂志比较特殊，自引率高。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0175414027, createdName=ms5109743545865402, createdTime=Mon Sep 12 10:39:51 CST 2016, time=2016-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=520470, encodeId=c4a75204e020, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：两天被拒，理由是IF6.36, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=401, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fce21636594, createdName=13214336, createdTime=Mon Mar 21 08:04:00 CST 2016, time=2016-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=520091, encodeId=fca452009165, content=尤其偏重临床研究，动物和细胞研究很快就会被拒！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=419, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae1a91281, createdName=www12345, createdTime=Fri Mar 11 11:25:00 CST 2016, time=2016-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514231, encodeId=ce6c5142318f, content=跟肥胖相关的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=530, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=886c1626433, createdName=hlycom3356@126, createdTime=Tue Aug 04 19:37:00 CST 2015, time=2015-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=502489, encodeId=974a502489af, content=这个杂志偏重于临床研究，投了一篇基础医学的分子生物学，被拒了，很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=531, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f18c101393, createdName=ideapad1234, createdTime=Wed Apr 23 12:04:00 CST 2014, time=2014-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=488743, encodeId=4cd0488e43e9, content=comment6,, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=603, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=name, createdTime=Sun Jun 03 22:12:00 CST 2012, time=2012-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=488734, encodeId=2cb8488e3457, content=comment1,, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=632, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=name, createdTime=Sun Jun 03 18:09:00 CST 2012, time=2012-06-03, status=1, ipAttribution=)]

2018-04-26 lalanihaoya

一般投稿多久会收到拒绝信？十天了一直是under review状态，感觉会悲剧的文章，只是想投投看看reviewer意见，

866 0

[GetPortalCommentsPageByObjectIdResponse(id=555444, encodeId=cb2155544477, content=一般投稿多久会收到拒绝信？十天了一直是under review状态，感觉会悲剧的文章，只是想投投看看reviewer意见，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=866, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c65a82050, createdName=lalanihaoya, createdTime=Thu Apr 26 23:04:00 CST 2018, time=2018-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555433, encodeId=dfb8555433bc, content=我想咨询下投稿后就会立即显示under review吗?谢谢!aug_fs_44765140 2018-04-10 12:40:00 发表: 回复很及时.两周果断被拒,不过editor态度很nice的.reviewers也给了不少建设性意见, beContent=aug_fs_44765140 2018-04-10 12:40:00 发表: 回复很及时.两周果断被拒,不过editor态度很nice的.reviewers也给了不少建设性意见, objectType=tool_impact_factor, channel=null, level=null, likeNumber=313, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=29d42068457, createdName=1361ef91b0m, createdTime=Thu Apr 26 00:00:00 CST 2018, time=2018-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554766, encodeId=b1d4554e66ee, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：回复很及时，两周果断被拒；不过editor态度很nice的，reviewers也给了不少建设性意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=379, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=40232188750, createdName=aug_fs_44765140, createdTime=Tue Apr 10 12:40:00 CST 2018, time=2018-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833794, encodeId=4fff833e943d, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：这个杂志比较特殊，自引率高。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0175414027, createdName=ms5109743545865402, createdTime=Mon Sep 12 10:39:51 CST 2016, time=2016-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=520470, encodeId=c4a75204e020, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：两天被拒，理由是IF6.36, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=401, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fce21636594, createdName=13214336, createdTime=Mon Mar 21 08:04:00 CST 2016, time=2016-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=520091, encodeId=fca452009165, content=尤其偏重临床研究，动物和细胞研究很快就会被拒！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=419, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae1a91281, createdName=www12345, createdTime=Fri Mar 11 11:25:00 CST 2016, time=2016-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514231, encodeId=ce6c5142318f, content=跟肥胖相关的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=530, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=886c1626433, createdName=hlycom3356@126, createdTime=Tue Aug 04 19:37:00 CST 2015, time=2015-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=502489, encodeId=974a502489af, content=这个杂志偏重于临床研究，投了一篇基础医学的分子生物学，被拒了，很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=531, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f18c101393, createdName=ideapad1234, createdTime=Wed Apr 23 12:04:00 CST 2014, time=2014-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=488743, encodeId=4cd0488e43e9, content=comment6,, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=603, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=name, createdTime=Sun Jun 03 22:12:00 CST 2012, time=2012-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=488734, encodeId=2cb8488e3457, content=comment1,, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=632, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=name, createdTime=Sun Jun 03 18:09:00 CST 2012, time=2012-06-03, status=1, ipAttribution=)]

2018-04-26 1361ef91b0m

我想咨询下投稿后就会立即显示under review吗?谢谢!aug_fs_44765140 2018-04-10 12:40:00 发表:
回复很及时.两周果断被拒,不过editor态度很nice的.reviewers也给了不少建设性意见

aug_fs_44765140 2018-04-10 12:40:00 发表: 回复很及时.两周果断被拒,不过editor态度很nice的.reviewers也给了不少建设性意见

313 0

[GetPortalCommentsPageByObjectIdResponse(id=555444, encodeId=cb2155544477, content=一般投稿多久会收到拒绝信？十天了一直是under review状态，感觉会悲剧的文章，只是想投投看看reviewer意见，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=866, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c65a82050, createdName=lalanihaoya, createdTime=Thu Apr 26 23:04:00 CST 2018, time=2018-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555433, encodeId=dfb8555433bc, content=我想咨询下投稿后就会立即显示under review吗?谢谢!aug_fs_44765140 2018-04-10 12:40:00 发表: 回复很及时.两周果断被拒,不过editor态度很nice的.reviewers也给了不少建设性意见, beContent=aug_fs_44765140 2018-04-10 12:40:00 发表: 回复很及时.两周果断被拒,不过editor态度很nice的.reviewers也给了不少建设性意见, objectType=tool_impact_factor, channel=null, level=null, likeNumber=313, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=29d42068457, createdName=1361ef91b0m, createdTime=Thu Apr 26 00:00:00 CST 2018, time=2018-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554766, encodeId=b1d4554e66ee, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：回复很及时，两周果断被拒；不过editor态度很nice的，reviewers也给了不少建设性意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=379, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=40232188750, createdName=aug_fs_44765140, createdTime=Tue Apr 10 12:40:00 CST 2018, time=2018-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833794, encodeId=4fff833e943d, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：这个杂志比较特殊，自引率高。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0175414027, createdName=ms5109743545865402, createdTime=Mon Sep 12 10:39:51 CST 2016, time=2016-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=520470, encodeId=c4a75204e020, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：两天被拒，理由是IF6.36, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=401, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fce21636594, createdName=13214336, createdTime=Mon Mar 21 08:04:00 CST 2016, time=2016-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=520091, encodeId=fca452009165, content=尤其偏重临床研究，动物和细胞研究很快就会被拒！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=419, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae1a91281, createdName=www12345, createdTime=Fri Mar 11 11:25:00 CST 2016, time=2016-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514231, encodeId=ce6c5142318f, content=跟肥胖相关的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=530, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=886c1626433, createdName=hlycom3356@126, createdTime=Tue Aug 04 19:37:00 CST 2015, time=2015-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=502489, encodeId=974a502489af, content=这个杂志偏重于临床研究，投了一篇基础医学的分子生物学，被拒了，很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=531, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f18c101393, createdName=ideapad1234, createdTime=Wed Apr 23 12:04:00 CST 2014, time=2014-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=488743, encodeId=4cd0488e43e9, content=comment6,, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=603, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=name, createdTime=Sun Jun 03 22:12:00 CST 2012, time=2012-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=488734, encodeId=2cb8488e3457, content=comment1,, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=632, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=name, createdTime=Sun Jun 03 18:09:00 CST 2012, time=2012-06-03, status=1, ipAttribution=)]

2018-04-10 aug_fs_44765140

审稿速度:1.0 | 投稿命中率:25.0
经验分享：回复很及时，两周果断被拒；不过editor态度很nice的，reviewers也给了不少建设性意见

379 0

[GetPortalCommentsPageByObjectIdResponse(id=555444, encodeId=cb2155544477, content=一般投稿多久会收到拒绝信？十天了一直是under review状态，感觉会悲剧的文章，只是想投投看看reviewer意见，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=866, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c65a82050, createdName=lalanihaoya, createdTime=Thu Apr 26 23:04:00 CST 2018, time=2018-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555433, encodeId=dfb8555433bc, content=我想咨询下投稿后就会立即显示under review吗?谢谢!aug_fs_44765140 2018-04-10 12:40:00 发表: 回复很及时.两周果断被拒,不过editor态度很nice的.reviewers也给了不少建设性意见, beContent=aug_fs_44765140 2018-04-10 12:40:00 发表: 回复很及时.两周果断被拒,不过editor态度很nice的.reviewers也给了不少建设性意见, objectType=tool_impact_factor, channel=null, level=null, likeNumber=313, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=29d42068457, createdName=1361ef91b0m, createdTime=Thu Apr 26 00:00:00 CST 2018, time=2018-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554766, encodeId=b1d4554e66ee, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：回复很及时，两周果断被拒；不过editor态度很nice的，reviewers也给了不少建设性意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=379, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=40232188750, createdName=aug_fs_44765140, createdTime=Tue Apr 10 12:40:00 CST 2018, time=2018-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833794, encodeId=4fff833e943d, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：这个杂志比较特殊，自引率高。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0175414027, createdName=ms5109743545865402, createdTime=Mon Sep 12 10:39:51 CST 2016, time=2016-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=520470, encodeId=c4a75204e020, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：两天被拒，理由是IF6.36, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=401, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fce21636594, createdName=13214336, createdTime=Mon Mar 21 08:04:00 CST 2016, time=2016-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=520091, encodeId=fca452009165, content=尤其偏重临床研究，动物和细胞研究很快就会被拒！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=419, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae1a91281, createdName=www12345, createdTime=Fri Mar 11 11:25:00 CST 2016, time=2016-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514231, encodeId=ce6c5142318f, content=跟肥胖相关的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=530, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=886c1626433, createdName=hlycom3356@126, createdTime=Tue Aug 04 19:37:00 CST 2015, time=2015-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=502489, encodeId=974a502489af, content=这个杂志偏重于临床研究，投了一篇基础医学的分子生物学，被拒了，很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=531, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f18c101393, createdName=ideapad1234, createdTime=Wed Apr 23 12:04:00 CST 2014, time=2014-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=488743, encodeId=4cd0488e43e9, content=comment6,, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=603, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=name, createdTime=Sun Jun 03 22:12:00 CST 2012, time=2012-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=488734, encodeId=2cb8488e3457, content=comment1,, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=632, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=name, createdTime=Sun Jun 03 18:09:00 CST 2012, time=2012-06-03, status=1, ipAttribution=)]

2016-09-12 ms5109743545865402

审稿速度:1.0 | 投稿命中率:25.0
经验分享：这个杂志比较特殊，自引率高。

100 0

[GetPortalCommentsPageByObjectIdResponse(id=555444, encodeId=cb2155544477, content=一般投稿多久会收到拒绝信？十天了一直是under review状态，感觉会悲剧的文章，只是想投投看看reviewer意见，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=866, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c65a82050, createdName=lalanihaoya, createdTime=Thu Apr 26 23:04:00 CST 2018, time=2018-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555433, encodeId=dfb8555433bc, content=我想咨询下投稿后就会立即显示under review吗?谢谢!aug_fs_44765140 2018-04-10 12:40:00 发表: 回复很及时.两周果断被拒,不过editor态度很nice的.reviewers也给了不少建设性意见, beContent=aug_fs_44765140 2018-04-10 12:40:00 发表: 回复很及时.两周果断被拒,不过editor态度很nice的.reviewers也给了不少建设性意见, objectType=tool_impact_factor, channel=null, level=null, likeNumber=313, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=29d42068457, createdName=1361ef91b0m, createdTime=Thu Apr 26 00:00:00 CST 2018, time=2018-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554766, encodeId=b1d4554e66ee, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：回复很及时，两周果断被拒；不过editor态度很nice的，reviewers也给了不少建设性意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=379, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=40232188750, createdName=aug_fs_44765140, createdTime=Tue Apr 10 12:40:00 CST 2018, time=2018-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833794, encodeId=4fff833e943d, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：这个杂志比较特殊，自引率高。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0175414027, createdName=ms5109743545865402, createdTime=Mon Sep 12 10:39:51 CST 2016, time=2016-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=520470, encodeId=c4a75204e020, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：两天被拒，理由是IF6.36, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=401, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fce21636594, createdName=13214336, createdTime=Mon Mar 21 08:04:00 CST 2016, time=2016-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=520091, encodeId=fca452009165, content=尤其偏重临床研究，动物和细胞研究很快就会被拒！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=419, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae1a91281, createdName=www12345, createdTime=Fri Mar 11 11:25:00 CST 2016, time=2016-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514231, encodeId=ce6c5142318f, content=跟肥胖相关的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=530, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=886c1626433, createdName=hlycom3356@126, createdTime=Tue Aug 04 19:37:00 CST 2015, time=2015-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=502489, encodeId=974a502489af, content=这个杂志偏重于临床研究，投了一篇基础医学的分子生物学，被拒了，很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=531, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f18c101393, createdName=ideapad1234, createdTime=Wed Apr 23 12:04:00 CST 2014, time=2014-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=488743, encodeId=4cd0488e43e9, content=comment6,, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=603, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=name, createdTime=Sun Jun 03 22:12:00 CST 2012, time=2012-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=488734, encodeId=2cb8488e3457, content=comment1,, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=632, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=name, createdTime=Sun Jun 03 18:09:00 CST 2012, time=2012-06-03, status=1, ipAttribution=)]

2016-03-21 13214336

审稿速度:1.0 | 投稿命中率:25.0
经验分享：两天被拒，理由是IF6.36

401 0

[GetPortalCommentsPageByObjectIdResponse(id=555444, encodeId=cb2155544477, content=一般投稿多久会收到拒绝信？十天了一直是under review状态，感觉会悲剧的文章，只是想投投看看reviewer意见，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=866, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c65a82050, createdName=lalanihaoya, createdTime=Thu Apr 26 23:04:00 CST 2018, time=2018-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555433, encodeId=dfb8555433bc, content=我想咨询下投稿后就会立即显示under review吗?谢谢!aug_fs_44765140 2018-04-10 12:40:00 发表: 回复很及时.两周果断被拒,不过editor态度很nice的.reviewers也给了不少建设性意见, beContent=aug_fs_44765140 2018-04-10 12:40:00 发表: 回复很及时.两周果断被拒,不过editor态度很nice的.reviewers也给了不少建设性意见, objectType=tool_impact_factor, channel=null, level=null, likeNumber=313, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=29d42068457, createdName=1361ef91b0m, createdTime=Thu Apr 26 00:00:00 CST 2018, time=2018-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554766, encodeId=b1d4554e66ee, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：回复很及时，两周果断被拒；不过editor态度很nice的，reviewers也给了不少建设性意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=379, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=40232188750, createdName=aug_fs_44765140, createdTime=Tue Apr 10 12:40:00 CST 2018, time=2018-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833794, encodeId=4fff833e943d, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：这个杂志比较特殊，自引率高。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0175414027, createdName=ms5109743545865402, createdTime=Mon Sep 12 10:39:51 CST 2016, time=2016-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=520470, encodeId=c4a75204e020, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：两天被拒，理由是IF6.36, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=401, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fce21636594, createdName=13214336, createdTime=Mon Mar 21 08:04:00 CST 2016, time=2016-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=520091, encodeId=fca452009165, content=尤其偏重临床研究，动物和细胞研究很快就会被拒！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=419, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae1a91281, createdName=www12345, createdTime=Fri Mar 11 11:25:00 CST 2016, time=2016-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514231, encodeId=ce6c5142318f, content=跟肥胖相关的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=530, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=886c1626433, createdName=hlycom3356@126, createdTime=Tue Aug 04 19:37:00 CST 2015, time=2015-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=502489, encodeId=974a502489af, content=这个杂志偏重于临床研究，投了一篇基础医学的分子生物学，被拒了，很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=531, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f18c101393, createdName=ideapad1234, createdTime=Wed Apr 23 12:04:00 CST 2014, time=2014-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=488743, encodeId=4cd0488e43e9, content=comment6,, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=603, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=name, createdTime=Sun Jun 03 22:12:00 CST 2012, time=2012-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=488734, encodeId=2cb8488e3457, content=comment1,, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=632, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=name, createdTime=Sun Jun 03 18:09:00 CST 2012, time=2012-06-03, status=1, ipAttribution=)]

2016-03-11 www12345

尤其偏重临床研究，动物和细胞研究很快就会被拒！

419 0

[GetPortalCommentsPageByObjectIdResponse(id=555444, encodeId=cb2155544477, content=一般投稿多久会收到拒绝信？十天了一直是under review状态，感觉会悲剧的文章，只是想投投看看reviewer意见，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=866, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c65a82050, createdName=lalanihaoya, createdTime=Thu Apr 26 23:04:00 CST 2018, time=2018-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555433, encodeId=dfb8555433bc, content=我想咨询下投稿后就会立即显示under review吗?谢谢!aug_fs_44765140 2018-04-10 12:40:00 发表: 回复很及时.两周果断被拒,不过editor态度很nice的.reviewers也给了不少建设性意见, beContent=aug_fs_44765140 2018-04-10 12:40:00 发表: 回复很及时.两周果断被拒,不过editor态度很nice的.reviewers也给了不少建设性意见, objectType=tool_impact_factor, channel=null, level=null, likeNumber=313, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=29d42068457, createdName=1361ef91b0m, createdTime=Thu Apr 26 00:00:00 CST 2018, time=2018-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554766, encodeId=b1d4554e66ee, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：回复很及时，两周果断被拒；不过editor态度很nice的，reviewers也给了不少建设性意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=379, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=40232188750, createdName=aug_fs_44765140, createdTime=Tue Apr 10 12:40:00 CST 2018, time=2018-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833794, encodeId=4fff833e943d, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：这个杂志比较特殊，自引率高。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0175414027, createdName=ms5109743545865402, createdTime=Mon Sep 12 10:39:51 CST 2016, time=2016-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=520470, encodeId=c4a75204e020, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：两天被拒，理由是IF6.36, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=401, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fce21636594, createdName=13214336, createdTime=Mon Mar 21 08:04:00 CST 2016, time=2016-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=520091, encodeId=fca452009165, content=尤其偏重临床研究，动物和细胞研究很快就会被拒！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=419, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae1a91281, createdName=www12345, createdTime=Fri Mar 11 11:25:00 CST 2016, time=2016-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514231, encodeId=ce6c5142318f, content=跟肥胖相关的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=530, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=886c1626433, createdName=hlycom3356@126, createdTime=Tue Aug 04 19:37:00 CST 2015, time=2015-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=502489, encodeId=974a502489af, content=这个杂志偏重于临床研究，投了一篇基础医学的分子生物学，被拒了，很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=531, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f18c101393, createdName=ideapad1234, createdTime=Wed Apr 23 12:04:00 CST 2014, time=2014-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=488743, encodeId=4cd0488e43e9, content=comment6,, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=603, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=name, createdTime=Sun Jun 03 22:12:00 CST 2012, time=2012-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=488734, encodeId=2cb8488e3457, content=comment1,, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=632, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=name, createdTime=Sun Jun 03 18:09:00 CST 2012, time=2012-06-03, status=1, ipAttribution=)]

2015-08-04 hlycom3356@126

跟肥胖相关的杂志

530 0

[GetPortalCommentsPageByObjectIdResponse(id=555444, encodeId=cb2155544477, content=一般投稿多久会收到拒绝信？十天了一直是under review状态，感觉会悲剧的文章，只是想投投看看reviewer意见，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=866, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c65a82050, createdName=lalanihaoya, createdTime=Thu Apr 26 23:04:00 CST 2018, time=2018-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555433, encodeId=dfb8555433bc, content=我想咨询下投稿后就会立即显示under review吗?谢谢!aug_fs_44765140 2018-04-10 12:40:00 发表: 回复很及时.两周果断被拒,不过editor态度很nice的.reviewers也给了不少建设性意见, beContent=aug_fs_44765140 2018-04-10 12:40:00 发表: 回复很及时.两周果断被拒,不过editor态度很nice的.reviewers也给了不少建设性意见, objectType=tool_impact_factor, channel=null, level=null, likeNumber=313, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=29d42068457, createdName=1361ef91b0m, createdTime=Thu Apr 26 00:00:00 CST 2018, time=2018-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554766, encodeId=b1d4554e66ee, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：回复很及时，两周果断被拒；不过editor态度很nice的，reviewers也给了不少建设性意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=379, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=40232188750, createdName=aug_fs_44765140, createdTime=Tue Apr 10 12:40:00 CST 2018, time=2018-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833794, encodeId=4fff833e943d, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：这个杂志比较特殊，自引率高。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0175414027, createdName=ms5109743545865402, createdTime=Mon Sep 12 10:39:51 CST 2016, time=2016-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=520470, encodeId=c4a75204e020, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：两天被拒，理由是IF6.36, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=401, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fce21636594, createdName=13214336, createdTime=Mon Mar 21 08:04:00 CST 2016, time=2016-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=520091, encodeId=fca452009165, content=尤其偏重临床研究，动物和细胞研究很快就会被拒！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=419, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae1a91281, createdName=www12345, createdTime=Fri Mar 11 11:25:00 CST 2016, time=2016-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514231, encodeId=ce6c5142318f, content=跟肥胖相关的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=530, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=886c1626433, createdName=hlycom3356@126, createdTime=Tue Aug 04 19:37:00 CST 2015, time=2015-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=502489, encodeId=974a502489af, content=这个杂志偏重于临床研究，投了一篇基础医学的分子生物学，被拒了，很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=531, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f18c101393, createdName=ideapad1234, createdTime=Wed Apr 23 12:04:00 CST 2014, time=2014-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=488743, encodeId=4cd0488e43e9, content=comment6,, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=603, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=name, createdTime=Sun Jun 03 22:12:00 CST 2012, time=2012-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=488734, encodeId=2cb8488e3457, content=comment1,, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=632, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=name, createdTime=Sun Jun 03 18:09:00 CST 2012, time=2012-06-03, status=1, ipAttribution=)]

2014-04-23 ideapad1234

这个杂志偏重于临床研究，投了一篇基础医学的分子生物学，被拒了，很快

531 0

[GetPortalCommentsPageByObjectIdResponse(id=555444, encodeId=cb2155544477, content=一般投稿多久会收到拒绝信？十天了一直是under review状态，感觉会悲剧的文章，只是想投投看看reviewer意见，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=866, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c65a82050, createdName=lalanihaoya, createdTime=Thu Apr 26 23:04:00 CST 2018, time=2018-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555433, encodeId=dfb8555433bc, content=我想咨询下投稿后就会立即显示under review吗?谢谢!aug_fs_44765140 2018-04-10 12:40:00 发表: 回复很及时.两周果断被拒,不过editor态度很nice的.reviewers也给了不少建设性意见, beContent=aug_fs_44765140 2018-04-10 12:40:00 发表: 回复很及时.两周果断被拒,不过editor态度很nice的.reviewers也给了不少建设性意见, objectType=tool_impact_factor, channel=null, level=null, likeNumber=313, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=29d42068457, createdName=1361ef91b0m, createdTime=Thu Apr 26 00:00:00 CST 2018, time=2018-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554766, encodeId=b1d4554e66ee, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：回复很及时，两周果断被拒；不过editor态度很nice的，reviewers也给了不少建设性意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=379, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=40232188750, createdName=aug_fs_44765140, createdTime=Tue Apr 10 12:40:00 CST 2018, time=2018-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833794, encodeId=4fff833e943d, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：这个杂志比较特殊，自引率高。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0175414027, createdName=ms5109743545865402, createdTime=Mon Sep 12 10:39:51 CST 2016, time=2016-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=520470, encodeId=c4a75204e020, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：两天被拒，理由是IF6.36, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=401, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fce21636594, createdName=13214336, createdTime=Mon Mar 21 08:04:00 CST 2016, time=2016-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=520091, encodeId=fca452009165, content=尤其偏重临床研究，动物和细胞研究很快就会被拒！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=419, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae1a91281, createdName=www12345, createdTime=Fri Mar 11 11:25:00 CST 2016, time=2016-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514231, encodeId=ce6c5142318f, content=跟肥胖相关的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=530, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=886c1626433, createdName=hlycom3356@126, createdTime=Tue Aug 04 19:37:00 CST 2015, time=2015-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=502489, encodeId=974a502489af, content=这个杂志偏重于临床研究，投了一篇基础医学的分子生物学，被拒了，很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=531, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f18c101393, createdName=ideapad1234, createdTime=Wed Apr 23 12:04:00 CST 2014, time=2014-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=488743, encodeId=4cd0488e43e9, content=comment6,, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=603, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=name, createdTime=Sun Jun 03 22:12:00 CST 2012, time=2012-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=488734, encodeId=2cb8488e3457, content=comment1,, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=632, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=name, createdTime=Sun Jun 03 18:09:00 CST 2012, time=2012-06-03, status=1, ipAttribution=)]

2012-06-03 name

comment6,

603 0

[GetPortalCommentsPageByObjectIdResponse(id=555444, encodeId=cb2155544477, content=一般投稿多久会收到拒绝信？十天了一直是under review状态，感觉会悲剧的文章，只是想投投看看reviewer意见，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=866, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c65a82050, createdName=lalanihaoya, createdTime=Thu Apr 26 23:04:00 CST 2018, time=2018-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555433, encodeId=dfb8555433bc, content=我想咨询下投稿后就会立即显示under review吗?谢谢!aug_fs_44765140 2018-04-10 12:40:00 发表: 回复很及时.两周果断被拒,不过editor态度很nice的.reviewers也给了不少建设性意见, beContent=aug_fs_44765140 2018-04-10 12:40:00 发表: 回复很及时.两周果断被拒,不过editor态度很nice的.reviewers也给了不少建设性意见, objectType=tool_impact_factor, channel=null, level=null, likeNumber=313, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=29d42068457, createdName=1361ef91b0m, createdTime=Thu Apr 26 00:00:00 CST 2018, time=2018-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554766, encodeId=b1d4554e66ee, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：回复很及时，两周果断被拒；不过editor态度很nice的，reviewers也给了不少建设性意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=379, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=40232188750, createdName=aug_fs_44765140, createdTime=Tue Apr 10 12:40:00 CST 2018, time=2018-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833794, encodeId=4fff833e943d, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：这个杂志比较特殊，自引率高。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0175414027, createdName=ms5109743545865402, createdTime=Mon Sep 12 10:39:51 CST 2016, time=2016-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=520470, encodeId=c4a75204e020, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：两天被拒，理由是IF6.36, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=401, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fce21636594, createdName=13214336, createdTime=Mon Mar 21 08:04:00 CST 2016, time=2016-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=520091, encodeId=fca452009165, content=尤其偏重临床研究，动物和细胞研究很快就会被拒！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=419, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae1a91281, createdName=www12345, createdTime=Fri Mar 11 11:25:00 CST 2016, time=2016-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514231, encodeId=ce6c5142318f, content=跟肥胖相关的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=530, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=886c1626433, createdName=hlycom3356@126, createdTime=Tue Aug 04 19:37:00 CST 2015, time=2015-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=502489, encodeId=974a502489af, content=这个杂志偏重于临床研究，投了一篇基础医学的分子生物学，被拒了，很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=531, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f18c101393, createdName=ideapad1234, createdTime=Wed Apr 23 12:04:00 CST 2014, time=2014-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=488743, encodeId=4cd0488e43e9, content=comment6,, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=603, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=name, createdTime=Sun Jun 03 22:12:00 CST 2012, time=2012-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=488734, encodeId=2cb8488e3457, content=comment1,, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=632, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=name, createdTime=Sun Jun 03 18:09:00 CST 2012, time=2012-06-03, status=1, ipAttribution=)]

2012-06-03 name

comment1,

632 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务